Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/71378
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Identification and functional characterization of two novel mutations in the α-helical loop (residues 484-503) of CYBB/gp91phox resulting in the rare X91⁺ variant of chronic granulomatous disease |
Other Titles: | Identification and functional characterization of two novel mutations in the alpha-helical loop (residues 484-503) of CYBB/gp91phox resulting in the rare X91(+) variant of chronic granulomatous disease |
Author: | Boog, B. Quach, A. Costabile, M. Smart, J. Quinn, P. Singh, H. Gold, M. Booker, G. Choo, S. Hii, C. Ferrante, A. |
Citation: | Human Mutation, 2012; 33(3):471-475 |
Publisher: | Wiley-Liss |
Issue Date: | 2012 |
ISSN: | 1059-7794 1098-1004 |
Statement of Responsibility: | Bernadette Boog, Alex Quach, Maurizio Costabile, Joanne Smart, Patrick Quinn, Harmeet Singh, Michael Gold, Grant Booker, Sharon Choo, Charles S. Hii, and Antonio Ferrante |
Abstract: | Chronic granulomatous disease (CGD) is mainly caused by mutations in X-linked CYBB that encodes gp91. We have identified two novel mutations in CYBB resulting in the rare X91(+)-CGD variant, c.1500T>G (p.Asp500Glu) in two male siblings and c.1463C>A (p.Ala488Asp) in an unrelated male. Zymosan and/or PMA (Phorbol 12-myristate 13-acetate)-induced recruitment of p47(phox) and p67(phox) to the membrane fraction was normal for both mutants. Cell-free assays using recombinant wild-type and the mutant proteins revealed that these mutants were not activated by NADPH (nicotinamide adenine dinucleotide phosphate). Interestingly, the Ala488Asp mutant was activated by NADPH in the presence of glutathione. These data suggest that the mutations prevented NADPH from binding to gp91(phox) and the requirement of a negative charge at residue 500 in gp91(phox) for NADPH oxidase assembly, in contrast to a previously described Asp500Gly change. These mutations and the effect of glutathione provide a unique insight into disease pathogenesis and potential therapy in variant X91(+)-CGD. |
Keywords: | chronic granulomatous disease (CGD) CYBB |
Rights: | © 2011 Wiley Periodicals, Inc. |
DOI: | 10.1002/humu.22003 |
Published version: | http://dx.doi.org/10.1002/humu.22003 |
Appears in Collections: | Aurora harvest Paediatrics publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.